MedTrace Logo

Epicardial Fat, Visceral Fat and Coronary Atherosclerosis

NCT01344694 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 110

Last updated 2011-05-16

No results posted yet for this study

Summary

Background: Visceral fat is increasingly associated with metabolic syndrome and with fatty liver, a condition carrying a high risk of cardiovascular disease. The independent role of epicardial fat deposition in cardiovascular risk remains unclear.

Conditions

Interventions

OTHER

patient with liver fat

30 patient with liver fat

OTHER

pts. with excess of visceral fat

pts. with excess of visceral fat

OTHER

control

30 control subjects

Sponsors & Collaborators

  • Ziv Hospital

    lead OTHER_GOV

Principal Investigators

  • Nimer Assy, md · Ziv MC

Eligibility

Min Age
40 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2011-07-31
Primary Completion
2012-02-29
Completion
2012-03-31

Countries

  • Israel

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01344694 on ClinicalTrials.gov